文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

COVID-19肺炎与流感A或B肺炎及无病毒性肺炎ICU患者早期和晚期血流与呼吸道合并感染发生率比较:威尔士多中心ICU队列研究

Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.
PubMed 文献 · Crit Care · 2022-06-02
一句话结论COVID-19肺炎ICU患者呼吸道合并感染40.5%、血流感染15.1%,高于无病毒性肺炎队列,与流感队列相似,三组死亡率相似。

该多中心回顾性观察性队列研究纳入威尔士7个ICU在2020年3月10日至7月31日期间收治的299例COVID-19肺炎连续患者,并与同期无病毒性肺炎患者173例及2017年11月20日起连续收治的流感A或B肺炎患者48例比较。COVID-19队列呼吸道合并感染发生率为40.5%、血流感染为15.1%;48小时内以金黄色葡萄球菌为主,48小时后以肠杆菌目革兰阴性菌为主。无病毒性肺炎队列呼吸道和血流感染率更低,流感队列与COVID-19队列相似。三组死亡率相似,未发现临床或人口学变量增加合并感染率和ICU死亡率。

要点

  • COVID-19肺炎ICU队列呼吸道合并感染发生率40.5%、血流感染15.1%。
  • COVID-19队列48小时内以金黄色葡萄球菌为主,48小时后以肠杆菌目革兰阴性菌为主。
  • 无病毒性肺炎ICU队列呼吸道和血流感染率低于COVID-19队列;流感A或B队列与COVID-19队列相似。
  • 三组死亡率相似,未发现临床或人口学变量增加合并感染率或ICU死亡率。

适用人群与场景

  • 威尔士7个ICU在2020年3月10日至7月31日收治的299例COVID-19肺炎连续患者(中位年龄57岁,男女比2:1)。
  • 同期同一ICU收治的无病毒性肺炎患者173例作为对照。
  • 2017年11月20日起连续收治的流感A或B肺炎患者48例作为对照。
  • 流感肺炎和无病毒性肺炎的对比数据来自7个参与ICU中的一个。

研究设计与关键结果

  • 研究类型:多中心、回顾性、观察性队列研究,比较COVID-19肺炎、流感A或B肺炎及无病毒性肺炎三组ICU患者的早期和晚期呼吸道及血流合并感染发生率。
  • COVID-19队列共299例成人,呼吸道合并感染发生率40.5%,血流合并感染发生率15.1%。
  • COVID-19队列48小时内以金黄色葡萄球菌为主要细菌病原体,48小时后以肠杆菌目革兰阴性菌为主。
  • 无病毒性肺炎队列呼吸道感染率和血流感染率低于COVID-19队列;流感队列呼吸道感染率和血流感染率与COVID-19队列相似。
  • 三组死亡率相似;未发现临床或人口学变量增加合并感染率或ICU死亡率。

证据类型、等级与局限

  • 证据类型:多中心回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,与因呼吸支持收入ICU的无病毒性肺炎队列相比,COVID-19队列细菌合并感染发生率更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The aim is to characterise early and late respiratory and bloodstream co-infection in patients admitted to intensive care units (ICUs) with SARS-CoV-2-related acute hypoxemic respiratory failure (AHRF) needing respiratory support in seven ICUs within Wales, during the first wave of the COVID-19 pandemic. We compare the rate of positivity of different secondary pathogens and their antimicrobial sensitivity in three different patient groups: patients admitted to ICU with COVID-19 pneumonia, Influenza A or B pneumonia, and patients without viral pneumonia.

DESIGN: Multicentre, retrospective, observational cohort study with rapid microbiology data from Public Health Wales, sharing of clinical and demographic data from seven participating ICUs.

SETTING: Seven Welsh ICUs participated between 10 March and 31 July 2020. Clinical and demographic data for COVID-19 disease were shared by each participating centres, and microbiology data were extracted from a data repository within Public Health Wales. Comparative data were taken from a cohort of patients without viral pneumonia admitted to ICU during the same period as the COVID-19 cohort (referred to as no viral pneumonia or 'no viral' group), and to a retrospective non-matched cohort of consecutive patients with Influenza A or B admitted to ICUs from 20 November 2017. The comparative data for Influenza pneumonia and no viral pneumonia were taken from one of the seven participating ICUs.

PARTICIPANTS: A total of 299 consecutive patients admitted to ICUs with COVID-19 pneumonia were compared with 173 and 48 patients admitted with no viral pneumonia or Influenza A or B pneumonia, respectively.

MAIN OUTCOME MEASURES: Primary outcome was to calculate comparative incidence of early and late co-infection in patients admitted to ICU with COVID-19, Influenza A or B pneumonia and no viral pneumonia. Secondary outcome was to calculate the individual group of early and late co-infection rate on a per-patient and per-sample basis, with their antimicrobial susceptibility and thirdly to ascertain any statistical correlation between clinical and demographic variables with rate of acquiring co-infection following ICU admission.

RESULTS: A total of 299 adults (median age 57, M/F 2:1) were included in the COVID-19 ICU cohort. The incidence of respiratory and bloodstream co-infection was 40.5% and 15.1%, respectively. Staphylococcus aureus was the predominant bacterial pathogen within the first 48 h. Gram-negative organisms from Enterobacterales group were predominantly seen after 48 h in COVID-19 cohort. Comparative no viral pneumonia cohort had lower rates of respiratory tract infection and bloodstream infection. The influenza cohort had similar rates respiratory tract infection and bloodstream infection. Mortality in all three groups was similar, and no clinical or demographic variables were found to increase the rate of co-infection and ICU mortality.

CONCLUSIONS: Higher incidence of bacterial co-infection was found in COVID-19 cohort as compared to the no viral pneumonia cohort admitted to ICUs for respiratory support.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Pandey M, May A, Tan L, et al. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study. Crit Care. 2022. PMID: 35655224. doi:10.1186/s13054-022-04026-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。